Key result
Elevated postoperative procalcitonin linked to higher early mortality and wound infection after CABG.
Why the study?
Increased serum procalcitonin (PCT) is a known sign of postoperative complications in cardiac patients, motivating evaluation of its relationship with one-year morbidity and mortality after coronary artery bypass graft (CABG) surgery.
Does postoperative serum procalcitonin level predict one-year morbidity and mortality in patients undergoing coronary artery bypass graft surgery?
Cohort (n=100)
No
Does postoperative serum procalcitonin level predict one-year morbidity and mortality in patients undergoing coronary artery bypass graft surgery?
Elevated postoperative serum procalcitonin levels within 48 hours after CABG surgery are associated with higher rates of early mortality, sternal wound infection, and packed red blood cell transfusion.
Answers are grounded in this paper and cite their sources.
Does not support routine use for risk stratification after CABG; leaves open incremental value for one-year prediction.
BACKGROUND: The increased serum procalcitonin (PCT) level in cardiac patients is known as a sign of postoperative complications. OBJECTIVE: Considering the importance of predicting the incidence of both complications and mortality caused by coronary artery bypass graft (CABG) surgery, this study was conducted to determine the serum PCT level and its relationship with one-year morbidity and mortality among CABG patients. METHODS: This descriptive-analytical study was performed on 100 patients who underwent CABG surgery in Vali-e-Asr Hospital of Birjand, Iran. They were selected by a census sampling method from March 2014 to March 2015. The Elecsys BRAHMS PCT kit (Roche Company) was then used to measure the patients' serum PCT level. The required data were collected using the patients' medical records and telephone interviews with the patient or his/her relatives by passing one year from their discharge. The outcomes of this study comprised of mortality and morbidity causes (e.g., dysrhythmia, infection, and stroke). The data were then analyzed in SPSS version 16 by Mann-Whitney, chi-squared, and Fisher exact tests. In addition, a significant relationship was found between dyslipidemia and hypertension and early mortality rate in patients with high levels of PCT. Of note, risk-adjusted death did not differ significantly between the serum PCT levels after one year (RR, 0.068; 95% CI 0.008-0.566). CONCLUSION: Higher PCT serum levels in CABG patients are associated with the increased early mortality rate, sternum wound infection, and PC transfusion. Additionally, the other factors associated with mortality in the patients under study included dyslipidemia and hypertension.
No takes yet. Share an insight, caveat, or question.
Amouzeshi et al. (2021) conducted a cohort in Patients undergoing coronary artery bypass graft (CABG) surgery (n=100). Elevated postoperative serum procalcitonin (PCT) level (>0.8 ng/ml) vs. Normal postoperative serum procalcitonin (PCT) level (≤0.8 ng/ml) was evaluated on Risk-adjusted death at 1 year (early mortality) (RR 0.068, 95% CI 0.008-0.566, p=0.003). Higher postoperative serum procalcitonin levels in CABG patients were associated with early mortality and wound infection.
Synapse has enriched 10 related papers. Consider them for comparative context: